These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26861164)

  • 1. Teaching neurons to respond to placebos.
    Benedetti F; Frisaldi E; Carlino E; Giudetti L; Pampallona A; Zibetti M; Lanotte M; Lopiano L
    J Physiol; 2016 Oct; 594(19):5647-60. PubMed ID: 26861164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the thalamic-subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients.
    Frisaldi E; Carlino E; Lanotte M; Lopiano L; Benedetti F
    Cortex; 2014 Nov; 60():3-9. PubMed ID: 24457096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response.
    Benedetti F; Lanotte M; Colloca L; Ducati A; Zibetti M; Lopiano L
    J Physiol; 2009 Aug; 587(Pt 15):3869-83. PubMed ID: 19546163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus.
    Benedetti F; Colloca L; Torre E; Lanotte M; Melcarne A; Pesare M; Bergamasco B; Lopiano L
    Nat Neurosci; 2004 Jun; 7(6):587-8. PubMed ID: 15146189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning.
    Frisaldi E; Carlino E; Zibetti M; Barbiani D; Dematteis F; Lanotte M; Lopiano L; Benedetti F
    Mov Disord; 2017 Oct; 32(10):1474-1478. PubMed ID: 28895186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Placebo effect in Parkinson's disease].
    Miwa H
    No To Shinkei; 2007 Feb; 59(2):139-46. PubMed ID: 17315755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apomorphine reduces subthalamic neuronal entropy in parkinsonian patients.
    Lafreniere-Roula M; Darbin O; Hutchison WD; Wichmann T; Lozano AM; Dostrovsky JO
    Exp Neurol; 2010 Oct; 225(2):455-8. PubMed ID: 20659454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine.
    Lozano AM; Lang AE; Levy R; Hutchison W; Dostrovsky J
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S141-6. PubMed ID: 10762141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
    de la Fuente-Fernández R; Ruth TJ; Sossi V; Schulzer M; Calne DB; Stoessl AJ
    Science; 2001 Aug; 293(5532):1164-6. PubMed ID: 11498597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease.
    Alegret M; Valldeoriola F; Martí M; Pilleri M; Junqué C; Rumià J; Tolosa E
    Mov Disord; 2004 Dec; 19(12):1463-9. PubMed ID: 15390065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson's disease.
    Levy R; Dostrovsky JO; Lang AE; Sime E; Hutchison WD; Lozano AM
    J Neurophysiol; 2001 Jul; 86(1):249-60. PubMed ID: 11431506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The placebo effect on resting tremor in Parkinson's disease: an electrophysiological study.
    Barbagallo G; Nisticò R; Vescio B; Cerasa A; Olivadese G; Nigro S; Crasà M; Quattrone A; Bianco MG; Morelli M; Augimeri A; Salsone M; Novellino F; Nicoletti G; Arabia G; Quattrone A
    Parkinsonism Relat Disord; 2018 Jul; 52():17-23. PubMed ID: 29551396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo responses in Parkinson's disease.
    Lou JS
    Int Rev Neurobiol; 2020; 153():187-211. PubMed ID: 32563288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications.
    Verhagen Metman L; Locatelli ER; Bravi D; Mouradian MM; Chase TN
    Neurology; 1997 Feb; 48(2):369-72. PubMed ID: 9040723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractal characteristics of human Parkinsonian neuronal spike trains.
    Rasouli G; Rasouli M; Lenz FA; Verhagen L; Borrett DS; Kwan HC
    Neuroscience; 2006; 139(3):1153-8. PubMed ID: 16515843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of expectation on placebo-induced dopamine release in Parkinson disease.
    Lidstone SC; Schulzer M; Dinelle K; Mak E; Sossi V; Ruth TJ; de la Fuente-Fernández R; Phillips AG; Stoessl AJ
    Arch Gen Psychiatry; 2010 Aug; 67(8):857-65. PubMed ID: 20679593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apomorphine pump in advanced Parkinson's disease: Effects on motor and nonmotor symptoms with brain metabolism correlations.
    Auffret M; Le Jeune F; Maurus A; Drapier S; Houvenaghel JF; Robert GH; Sauleau P; Vérin M
    J Neurol Sci; 2017 Jan; 372():279-287. PubMed ID: 28017228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.
    De Gaspari D; Siri C; Landi A; Cilia R; Bonetti A; Natuzzi F; Morgante L; Mariani CB; Sganzerla E; Pezzoli G; Antonini A
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):450-3. PubMed ID: 16543520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of apomorphine in Parkinson's disease.
    Stocchi F
    Neurol Sci; 2008 Dec; 29 Suppl 5():S383-6. PubMed ID: 19381769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.